EFFICACY OF A FIXED DOSE OF OMALIZUMAB DURING MULTI-ALLERGEN ORAL-IMMUNOTHERAPY

Category Primary study
JournalAnnals of Allergy, Asthma and Immunology
Year 2019
This article has no abstract
Epistemonikos ID: 985127a7262549454962b9854520bacf8a28d328
First added on: Feb 11, 2025